Allspring Global Investments
PASG icon

Allspring Global Investments’s Passage Bio PASG Stock Holding History

Allspring Global Investments’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,976
Closed -$184K – 2861
2022
Q1 		$184K Buy
+2,976
New +$245K ﹤0.01% 2592

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allspring Global Investments's PASG Position: Q2 2022 in Review

Allspring Global Investments sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 2,976 shares — an estimated $184K sold.

Allspring Global Investments first reported a position in PASG in Q1 2022 and held it in 1 quarter. The position peaked at $184K in Q1 2022. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Allspring Global Investments reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 2,976 Passage Bio shares in Q2 2022, an estimated $184K.
  • Allspring Global Investments first reported a position in Passage Bio in Q1 2022 and held it in 1 quarter.
  • Allspring Global Investments's Passage Bio position peaked at $184K in Q1 2022.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.